Gene signature developed based on programmed cell death to predict the therapeutic response and prognosis for liver hepatocellular carcinoma
Open Access
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Gene body hypomethylation of pyroptosis-related genes NLRP7, NLRP2, and NLRP3 facilitate non-invasive surveillance of hepatocellular carcinomaFunctional & Integrative Genomics, 2023
- A novel prognostic model based on immunogenic cell death-related genes for improved risk stratification in hepatocellular carcinoma patientsJournal of Cancer Research and Clinical Oncology, 2023
- Management of Hepatocellular CarcinomaJAMA Surgery, 2023
- Cancer‐associated fibroblast‐derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinibCancer Communications, 2023
- S100A9 Derived from Chemoembolization‐Induced Hypoxia Governs Mitochondrial Function in Hepatocellular Carcinoma ProgressionAdvanced Science, 2022
- Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification2020
- Nidogen 1‐Enriched Extracellular Vesicles Facilitate Extrahepatic Metastasis of Liver Cancer by Activating Pulmonary Fibroblasts to Secrete Tumor Necrosis Factor Receptor 1Advanced Science, 2020
- Programmed Cell Death, from a Cancer Perspective: An OverviewMolecular Diagnosis & Therapy, 2018
- Profiling Tumor Infiltrating Immune Cells with CIBERSORT2018
- Estimating and comparing time‐dependent areas under receiver operating characteristic curves for censored event times with competing risksStatistics in Medicine, 2013